Joint modeling of a single event time response with a longitudinal covariate dates back to the 1990s. The three basic types of joint modeling formulations are selection models, pattern mixture models and shared parameter models. The shared parameter models are most widely used. One type of a shared parameter model (Joint Model I) utilizes unobserved random effects to jointly model a longitudinal sub-model and a survival sub-model to assess the impact of an internal time-dependent covariate on the time-to-event response. Motivated by the Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet), we constructed a new model (Joint Model II), to jointly analyze correlated bivariate time-to-event responses associated with an internal time-dependent covariate in the Frequentist paradigm. This model exhibits two distinctive features: 1) a correlation between bivariate time-to-event responses and 2) a time-dependent internal covariate in both survival models. Developing a model that sufficiently accommodates both characteristics poses a challenge. To address this challenge, in addition to the random variables that account for the association between the time-to-event responses and the internal time-dependent covariate, a Gamma frailty random variable was used to account for the correlation between the two event time outcomes. To estimate the model parameters, we adopted the Expectation-Maximization (EM) algorithm. We built a complete joint likelihood function with respect to both latent variables and observed responses. The Gauss-Hermite quadrature method was employed to approximate the two-dimensional integrals in the E-step of the EM algorithm, and the maximum profile likelihood type of estimation method was implemented in the M-step. The bootstrap method was then applied to estimate the standard errors of the estimated model parameters. Simulation studies were conducted to examine the finite sample performance of the proposed methodology. Finally, the proposed method was applied to MD STARnet data to assess the impact of shortening fractions and steroid use on the onsets of scoliosis and mental health issues.

This thesis considers a variety of statistical issues related to the design and analysis of clinical trials involving multiple lifetime events. The use of composite endpoints, multivariate survival methods with dependent censoring, and recurrent events with dependent termination are considered. Much of this work is based on problems arising in oncology research. Composite endpoints are routinely adopted in multi-centre randomized trials designed to evaluate the effect of experimental interventions in cardiovascular disease, diabetes, and cancer. Despite their widespread use, relatively little attention has been paid to the statistical properties of estimators of treatment effect based on composite endpoints. In Chapter 2 we consider this issue in the context of multivariate models for time to event data in which copula functions link marginal distributions with a proportional hazards structure. We then examine the asymptotic and empirical properties of the estimator of treatment effect arising from a Cox regression model for the time to the first event. We point out that even when the treatment effect is the same for the component events, the limiting value of the estimator based on the composite endpoint is usually inconsistent for this common value. The limiting value is determined by the degree of association between the events, the stochastic ordering of events, and the censoring distribution. Within the framework adopted, marginal methods for the analysis of multivariate failure time data yield consistent estimators of treatment effect and are therefore preferred. We illustrate the methods by application to a recent asthma study. While there is considerable potential for more powerful tests of treatment effect when marginal methods are used, it is possible that problems related to dependent censoring can arise. This happens when the occurrence of one type of event increases the risk of withdrawal from a study and hence alters the probability of observing events of other types. The purpose of Chapter 3 is to formulate a model which reflects this type of mechanism, to evaluate the effect on the asymptotic and finite sample properties of marginal estimates, and to examine the performance of estimators obtained using flexible inverse probability weighted marginal estimating equations. Data from a motivating study are used for illustration. Clinical trials are often designed to assess the effect of therapeutic interventions on occurrence of recurrent events in the presence of a dependent terminal event such as death. Statistical methods based on multistate analysis have considerable appeal in this setting since they can incorporate changes in risk with each event occurrence, a dependence between the recurrent event and the terminal event and event-dependent censoring. To date, however, there has been limited methodology for the design of trials involving recurrent and terminal events, and we addresses this in Chapter 4. Based on the asymptotic distribution of regression coefficients from a multiplicative intensity Markov regression model, we derive sample size formulae to address power requirements for both the recurrent and terminal event processes. Superiority and non-inferiority trial designs are dealt with. Simulation studies confirm that the designs satisfy the nominal power requirements in both settings, and an application to a trial evaluating the effect of a bisphosphonate on skeletal complications is given for illustration.

This thesis considers a variety of statistical issues related to the design and analysis of clinical trials involving multiple lifetime events. The use of composite endpoints, multivariate survival methods with dependent censoring, and recurrent events with dependent termination are considered. Much of this work is based on problems arising in oncology research. Composite endpoints are routinely adopted in multi-centre randomized trials designed to evaluate the effect of experimental interventions in cardiovascular disease, diabetes, and cancer. Despite their widespread use, relatively little attention has been paid to the statistical properties of estimators of treatment effect based on composite endpoints. In Chapter 2 we consider this issue in the context of multivariate models for time to event data in which copula functions link marginal distributions with a proportional hazards structure. We then examine the asymptotic and empirical properties of the estimator of treatment effect arising from a Cox regression model for the time to the first event. We point out that even when the treatment effect is the same for the component events, the limiting value of the estimator based on the composite endpoint is usually inconsistent for this common value. The limiting value is determined by the degree of association between the events, the stochastic ordering of events, and the censoring distribution. Within the framework adopted, marginal methods for the analysis of multivariate failure time data yield consistent estimators of treatment effect and are therefore preferred. We illustrate the methods by application to a recent asthma study. While there is considerable potential for more powerful tests of treatment effect when marginal methods are used, it is possible that problems related to dependent censoring can arise. This happens when the occurrence of one type of event increases the risk of withdrawal from a study and hence alters the probability of observing events of other types. The purpose of Chapter 3 is to formulate a model which reflects this type of mechanism, to evaluate the effect on the asymptotic and finite sample properties of marginal estimates, and to examine the performance of estimators obtained using flexible inverse probability weighted marginal estimating equations. Data from a motivating study are used for illustration. Clinical trials are often designed to assess the effect of therapeutic interventions on occurrence of recurrent events in the presence of a dependent terminal event such as death. Statistical methods based on multistate analysis have considerable appeal in this setting since they can incorporate changes in risk with each event occurrence, a dependence between the recurrent event and the terminal event and event-dependent censoring. To date, however, there has been limited methodology for the design of trials involving recurrent and terminal events, and we addresses this in Chapter 4. Based on the asymptotic distribution of regression coefficients from a multiplicative intensity Markov regression model, we derive sample size formulae to address power requirements for both the recurrent and terminal event processes. Superiority and non-inferiority trial designs are dealt with. Simulation studies confirm that the designs satisfy the nominal power requirements in both settings, and an application to a trial evaluating the effect of a bisphosphonate on skeletal complications is given for illustration.

No description available.

Most statistical methods to design and analyze randomized controlled trials with time-to-event data, and synthesize their results in meta-analyses, use the hazard ratio (HR) as the measure of treatment effect. However, the HR relies on the proportional hazard assumption which is often violated, especially in cancer trials. In addition, the HR might be challenging to interpret and is frequently misinterpreted as a risk ratio (RR). In meta-analysis, conventional methods ignore that HRs are estimated over different time supports when the component trials have different follow-up durations. These issues also pertain to advanced statistical methods, such as network meta-analysis and surrogate endpoints validation. Novel methods that rely on the difference in restricted mean survival times (RMST) would help addressing these issues. In this dissertation, I first developed a Bayesian network meta-analysis model using the difference in RMST. This model synthesizes all the available evidence from multiple time points and treatment comparisons simultaneously through within-study covariance and between-study covariance for the differences in RMST. I proposed an estimator of the within-study covariance and estimated the model under the Bayesian framework. The simulation studies showed adequate performance in terms of mean bias and mean squared error. I illustrated the model on a network of randomized trials of second-line treatments of advanced non-small-cell lung cancer. Second, I introduced a novel two-stage meta-analytical model to evaluate trial-level surrogacy. I measured trial-level surrogacy by the coefficient of determination at multiple time points based on the differences in RMST. The model borrows strength across data available at multiple time points and enables assessing how the strength of surrogacy changes over time. Simulation studies showed that the estimates of coefficients of determination are unbiased and have high precision in almost all of the scenarios we examined. I demonstrated my model in two individual patient data meta-analyses in gastric cancer. Both methods, for network meta-analysis and surrogacy evaluation, have the advantage of not involving extrapolation beyond the observed time support in component trials and of not relying on the proportional hazard assumption. Finally, motivated by the common misinterpretation of the HR as a RR, I investigated the theoretical relationship between the HR and the RR and compared empirically the treatment effects measured by the HR and the RR in a large sample of oncology RCTs. When there is evidence of superiority for experimental group, misinterpreting the HR as the RR leads to overestimating the benefits by about 20%. / 2026-02-08T00:00:00Z

No description available.

Objectif: Explorer, adapter et développer de nouvelles méthodologies permettant de réaliser des revues systématiques et méta-analyses en chirurgie cardiaque. Méthodes: Le text mining et la citation chasing ont été utilisés pour l’optimisation de l’efficience et de la sensibilité de la recherche. Nous avons participé à l’évaluation des nouveaux outils (Risk of Bias 2.0 et Risk of bias in non-randomized studies of interventions) pour l’évaluation de la qualité des études randomisées et non randomisées et qui ont été adoptés pour nos projets futurs. Une nouvelle méthodologie graphique a été développée pour la réalisation des méta-analyses de données de survie. Résultats: Ces approches ont été utilisées pour répondre à diverses questions de recherche touchants différents aspects de la chirurgie cardiaque : 1) la rédaction des premières lignes directrices de l’Enhanced Recovery After Cardiac Surgery, 2) une revue systématique des résultats de la chirurgie valvulaire et aortique chez le transplanté cardiaque, démontrant les bons résultats de ces procédures dans une population à haut risque et l’émergence des techniques trans-cathéters dans la prise en charge de ces pathologies, 3) une méta-analyse portant sur les arythmies supra-ventriculaires chez les patients ayant eu une intervention de Fontan, concluant à un effet bénéfique de la technique du conduit extra-cardiaque et 4) une méta-analyse portant sur l’insuffisance aortique chez les patients porteurs d’assistance ventriculaire gauche, objectivant une incidence sous-estimée de cette situation clinique avec un impact significatif sur la survie de cette population de patients. Conclusion: Cette thèse aborde certaines contraintes de la littérature en chirurgie cardiaque comme la sensibilité sous optimale de la recherche systématique et les méta-analyses de données de survie, et a proposé des solutions. D’autres contraintes telles que les comparaisons multiples subsistent. Des recherches futures axées sur de nouvelles approches comme le network meta-analysis ou l’approche bayésienne pourraient offrir des solutions. / Objective: To explore, adapt and develop new methodologies for performing systematic reviews and meta-analyses in cardiac surgery. Methods: Text mining and citation chasing were used to optimize the efficiency and sensitivity of search process. We participated in the evaluation of new tools (Risk of Bias 2.0 and Risk of bias in non-randomized studies of interventions) for quality assessment of randomized and nonrandomized studies and we have adopted them for our future projects. A new graphic methodology has been developped for the performance of meta-analyses of time-to-event data. Results: These approaches have been used to answer various research questions touching different aspects of cardiac surgery: 1) writing the first guidelines of enhanced recovery after cardiac surgery, 2) a systematic review of the results of valvular surgery and aortic in cardiac transplantation, demonstrating good results of these procedures in a high-risk population and the emergence of trans-catheter techniques in the management of these pathologies, 3) a meta-analysis of supra-ventricular arrhythmias in patients who had a Fontan intervention, finding a beneficial effects of the extracardiac conduct technique and 4) a meta-analysis of aortic insufficiency in patients with left ventricular assist device, showing an under-estimated incidence of this clinical entity with a significant impact on the survival of this population of patients. Conclusion: This thesis addresses some of the short comings of the heart surgery literature such as the sensitivity of the systematic search and time-to-event data meta-anlysis and proposed novel solutions. Other issues such as the need to summarize a comprehensive and coherent set of comparisons remain. Future researchs focused on new approaches such as the network meta-analysis or the Bayesian approach can solve these issues.